Epstein Secrets

ned with a painting that resembled works by the French artist Jean Dubuffet. "The host coyly refuses to tell visitors who painted it," the reporter, Vicky Ward, wrote. The article was published around the same time that he started to recruit underage girls to the mansion, according to the indictment unsea

ublication's editor at the time, Graydon Carter, cut out first-person accounts of Epstein's treatment of women from a mother and her two daughters. Ward made the same claim in 2015, prompting a Vanity Fair spokesperson to note that "Epstein denied the charges at the time" and that the claims "were un

le headlined "I Tried to Warn You About Sleazy Billionaire Jeffrey Epstein in 2003." Welcome back to Democracy Now! It's great to have you with us, Vicky. VICKY WARD: Thanks, Amy. AMY GOODMAN: So, for people who do not understand who this man is—he's referred to as billionaire hedge fund manager Jef

t it contemplates his criminal prosecution." Kordel, 397 U.S. at 11-12 (emphasis added). In Kordel, a corporate executive was convicted of violating the Food, Drug, and Cosmetic Act partly on the basis of earlier answers to interrogatories served on his company by the Food and Drug Administration (FDA) in a ci

ned with a painting that resembled works by the French artist Jean Dubuffet. "The host coyly refuses to tell visitors who painted it," the reporter, Vicky Ward, wrote. The article was published around the same time that he started to recruit underage girls to the mansion, according to the indictment unsea

ublication's editor at the time, Graydon Carter, cut out first-person accounts of Epstein's treatment of women from a mother and her two daughters. Ward made the same claim in 2015, prompting a Vanity Fair spokesperson to note that "Epstein denied the charges at the time" and that the claims "were un

le headlined "I Tried to Warn You About Sleazy Billionaire Jeffrey Epstein in 2003." Welcome back to Democracy Now! It's great to have you with us, Vicky. VICKY WARD: Thanks, Amy. AMY GOODMAN: So, for people who do not understand who this man is—he's referred to as billionaire hedge fund manager Jef

it contemplates his criminal prosecution." Kordel, 397 U.S. at 11-12 (emphasis added). In Kordel, a corporate executive was convicted of violating the Food, Drug, and Cosmetic Act partly on the basis of earlier answers to interrogatories served on his company by the Food and Drug Administration (FDA) in a ci

t does not, at the time the applicant comes for- ward, have enough information to sustain a conviction

ith their access to the drug. The Supreme Court rejected the patients' claims. The Court agreed with FDA that the new drug approval provisions of the Food, Drug, and Cosmetic Act spe- cifically applied to the situation presented. (171 In one respect, however, the fact that Dr. Burzynski and his patients wer